enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. ICHD classification and diagnosis of migraine - Wikipedia

   en.wikipedia.org/wiki/ICHD_classification_and...

   The ICHD-2 specifies two different forms of the previously dubbed "menstrual migraine": pure menstrual migraine without aura and menstrually-related migraine without aura. The sole difference between these diagnoses is the occurrence of headache attacks outside of the 5-day period described in the diagnostic criteria.

3. Headache - Wikipedia

   en.wikipedia.org/wiki/Headache

   Headache, also known as cephalalgia, is the symptom of pain in the face, head, or neck.It can occur as a migraine, tension-type headache, or cluster headache. [1] [2] There is an increased risk of depression in those with severe headaches.

4. Scintillating scotoma - Wikipedia

   en.wikipedia.org/wiki/Scintillating_scotoma

   Symptoms typically appear gradually over 5 to 20 minutes and generally last less than 60 minutes, leading to the headache in classic migraine with aura, or resolving without consequence in acephalgic migraine. [3] For many sufferers, scintillating scotoma is first experienced as a prodrome to migraine, then without migraine later in life ...

5. Familial hemiplegic migraine - Wikipedia

   en.wikipedia.org/wiki/Familial_hemiplegic_migraine

   Familial hemiplegic migraine (FHM) is an autosomal dominant type of hemiplegic migraine that typically includes weakness of half the body which can last for hours, days, or weeks. It can be accompanied by other symptoms, such as ataxia, coma, and paralysis. Migraine attacks may be provoked by minor head trauma.

6. AOL Mail

   mail.aol.com

   Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

7. Migraine - Wikipedia

   en.wikipedia.org/wiki/Migraine

   In 2018, the first medication of a new class of drugs specifically designed for migraine prevention called calcitonin gene-related peptide receptor antagonists (CGRPs) was approved by the FDA. [20] As of July 2023, the FDA has approved eight drugs that act on the CGRP system for use in the treatment of migraine. [21]